Rodolphe Fischmeister
Orsay, 91400, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
A Closed Circulation Langendorff Heart Perfusion Method for Cardiac Drug Screening.
Journal: Physiological research
Published: February 04, 2025
Cardiac Gene Therapy With Phosphodiesterase 2A Limits Remodeling and Arrhythmias in Mouse Models of Heart Failure.
Journal: Journal of the American Heart Association
Published: February 03, 2025
Cardiac acetylcholinesterase and butyrylcholinesterase have distinct localization and function.
Journal: American journal of physiology. Heart and circulatory physiology
Published: January 21, 2025
Essential Role of the RIα Subunit of cAMP-Dependent Protein Kinase in Regulating Cardiac Contractility and Heart Failure Development.
Journal: Circulation
Published: October 02, 2024
Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure
Journal: Medecine sciences : M/S
Published: July 10, 2024
Cyclic nucleotide phosphodiesterases as drug targets.
Journal: Pharmacological reviews
Published: May 30, 2024
Membranes prime the RapGEF EPAC1 to transduce cAMP signaling.
Journal: Nature communications
Published: February 20, 2023
Distinct functions of cardiac β-adrenergic receptors in the T-tubule vs. outer surface membrane.
Journal: eLife
Published: October 17, 2022
EPAC1 inhibition protects the heart from doxorubicin-induced toxicity.
Journal: eLife
Published: September 29, 2022
Phosphodiesterases type 2, 3 and 4 promote vascular tone in mesenteric arteries from rats with heart failure.
Journal: European journal of pharmacology
Published: July 27, 2022
Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.
Journal: Nature reviews. Cardiology
Published: July 11, 2022
Last Updated: 09/26/2026